The concern of generic rivalry has consistently loomed around copyright’s iconic drug, Viagra, sparking questions about the prospects of related drug ventures. While first periods saw significant returns, the intellectual property end has created the way for cheaper alternatives, potentially lowering profitability and creating a significant hazar